Status:
COMPLETED
Pharmacist-Led Study in Controlling Hypoglycemia in Older Adults With Type 2 Diabetes Mellitus
Lead Sponsor:
University of Lincoln
Conditions:
Diabetes Mellitus Type 2 With Hypoglycemia
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study involves two parts: a randomised controlled trial, and a nested qualitative study. The main aim of the trial is to evaluate the effectiveness of a pharmacist-led, medications-focused patie...
Detailed Description
Hypoglycaemia is the most serious adverse effect of diabetes treatment. Older adults are at the highest risk to develop hypoglycaemia. Several studies have established the important positive role of e...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of type 2 Diabetes Mellitus
- Have been taking a sulfonylurea, insulin, or any three or more anti-diabetic medications
Exclusion
- Unable to understand instructions or to give consent.
- Impaired mental capacity
- On palliative care for cancer, with advanced-stage or end-stage diseases, who have psychosis or severe depression, who are terminally-ill, or with life expectancy \< 6 months
- Have been diagnosed with haemolytic anaemia or hemoglobinopathies as being self-reported or according to the patient's electronic record.
- Unwilling to take home glucose measurements or to use the glucometer (for example because of severe hearing or visual impairment and without a caregiver to measure the blood glucose level by the glucometer)
- Unwilling to return for follow up.
Key Trial Info
Start Date :
February 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT04081766
Start Date
February 9 2020
End Date
December 31 2020
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Abdullah University Hospital
Irbid, Jordan, 22110